ResearcherCancer Center AmsterdamActive in the last 2 years

L.C. Leeuwenburgh

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5098663808. Sources: OpenAlex.

Their work

Papers: 3 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 28

Papers, trials and grants by year

2025: 1 paper · 2026: 2 papers

Papers 3

The European Multidisciplinary Evidence-Based Guideline on Pancreatic Cancer: Methodological Protocol. Co-author DOI 10.1002/gin2.70074 ↗
The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localized pancreatic cancer: A nationwide analy… Co-author DOI 10.1016/j.ejca.2026.116822 ↗
Resectability stages of pancreatic cancer: nationwide reference. Last author DOI 10.1093/bjs/znaf120 ↗

Closest collaborators

The 25 strongest of 28 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Lois A. Daamen · 2 shared papers, 2025–2026 · strength 0.37
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
- Paper Resectability stages of pancreatic cancer: nationwide reference. DOI 10.1093/bjs/znaf120 ↗
Izaak Quintus Molenaar · 2 shared papers, 2025–2026 · strength 0.37
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
- Paper Resectability stages of pancreatic cancer: nationwide reference. DOI 10.1093/bjs/znaf120 ↗
Johanna W. Wilmink · 2 shared papers, 2025–2026 · strength 0.37
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
- Paper Resectability stages of pancreatic cancer: nationwide reference. DOI 10.1093/bjs/znaf120 ↗
Jeanin Elise van Hooft · 2 shared papers, 2025–2026 · strength 0.37
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
- Paper Resectability stages of pancreatic cancer: nationwide reference. DOI 10.1093/bjs/znaf120 ↗
Vincent Erwin de Meijer · 2 shared papers, 2025–2026 · strength 0.37
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
- Paper Resectability stages of pancreatic cancer: nationwide reference. DOI 10.1093/bjs/znaf120 ↗
Hanneke W.M. van Laarhoven · 2 shared papers, 2025–2026 · strength 0.37
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
- Paper Resectability stages of pancreatic cancer: nationwide reference. DOI 10.1093/bjs/znaf120 ↗
Lydia G. van der Geest · 2 shared papers, 2025–2026 · strength 0.37
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
- Paper Resectability stages of pancreatic cancer: nationwide reference. DOI 10.1093/bjs/znaf120 ↗
Judith de Vos‐Geelen · 2 shared papers, 2025–2026 · strength 0.37
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
- Paper Resectability stages of pancreatic cancer: nationwide reference. DOI 10.1093/bjs/znaf120 ↗
Ignace H. J. T. de Hingh · 2 shared papers, 2025–2026 · strength 0.37
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
- Paper Resectability stages of pancreatic cancer: nationwide reference. DOI 10.1093/bjs/znaf120 ↗
Bert A. Bonsing · 2 shared papers, 2025–2026 · strength 0.37
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
- Paper Resectability stages of pancreatic cancer: nationwide reference. DOI 10.1093/bjs/znaf120 ↗
Hjalmar C. van Santvoort · 2 shared papers, 2025–2026 · strength 0.37
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
- Paper Resectability stages of pancreatic cancer: nationwide reference. DOI 10.1093/bjs/znaf120 ↗
Marc G. Besselink · 2 shared papers, 2025–2026 · strength 0.37
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
- Paper Resectability stages of pancreatic cancer: nationwide reference. DOI 10.1093/bjs/znaf120 ↗
Martijn W.J. Stommel · 2 shared papers, 2025–2026 · strength 0.37
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
- Paper Resectability stages of pancreatic cancer: nationwide reference. DOI 10.1093/bjs/znaf120 ↗
Marjolein Y.V. Homs · 2 shared papers, 2025–2026 · strength 0.37
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
- Paper Resectability stages of pancreatic cancer: nationwide reference. DOI 10.1093/bjs/znaf120 ↗
Jacobien C.M. Scheepens · 1 shared paper, 2026 · strength 0.21
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
Robert C. Verdonk · 1 shared paper, 2026 · strength 0.21
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
Hanne D. Heerkens · 1 shared paper, 2026 · strength 0.21
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
Pauline A. J. Vissers · 1 shared paper, 2026 · strength 0.21
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
Guus Grimbergen · 1 shared paper, 2026 · strength 0.21
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
Gert J. Meijer · 1 shared paper, 2026 · strength 0.21
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
Peter G. Noordzij · 1 shared paper, 2026 · strength 0.21
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
Anna M E Bruynzeel · 1 shared paper, 2026 · strength 0.21
- Paper The impact of age on quality of life, 90-day mortality, adjuvant chemotherapy, and survival after treatment for localiz… DOI 10.1016/j.ejca.2026.116822 ↗
Ingmar Florin Rompen · 1 shared paper, 2025 · strength 0.17
- Paper Resectability stages of pancreatic cancer: nationwide reference. DOI 10.1093/bjs/znaf120 ↗
Inez M. Verpalen · 1 shared paper, 2025 · strength 0.17
- Paper Resectability stages of pancreatic cancer: nationwide reference. DOI 10.1093/bjs/znaf120 ↗
Bas Groot Koerkamp · 1 shared paper, 2025 · strength 0.17
- Paper Resectability stages of pancreatic cancer: nationwide reference. DOI 10.1093/bjs/znaf120 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.